PROCEPT BioRobotics Corporation announced that its Aquablation therapy has been assigned a Category I Current Procedural Terminology (CPT) code, which will take effect on January 1, 2026. This marks a ...
SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...
The American Medical Association (AMA) is expected to issue the first code for psychedelic therapy reimbursement, following the approval of a joint application submitted by MAPS PBC and COMPASS ...
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL ® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that the Centers for Medicare & ...